BioSpace News Archive

Hematological Malignancies Market: Demand for Immunotherapy to Remain Strong

Transparency Market Research witnesses the global hematological malignancies market has a highly fragmented competitive scenario.

May 21, 2020
·
4 min read
Lyophilized Injectable Drugs Market: Specialty Packaging Segment to Grow at Rapid Pace

Transparency Market Research has published a new report titled, “Lyophilized Injectable Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

May 21, 2020
·
5 min read
Medical Waste Containers Market: Reusable Containers to Be the Most Promising Usage Segment for Investment

The global medical waste containers market was valued at more than US$ 1,700.0 Mn in 2017 and is projected to expand at a cumulative annual growth rate of over 5.1% from 2018 to 2026, according to a new report published by Transparency Market Research titled ‘Medical Waste Containers Market

May 21, 2020
·
6 min read
Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations in Asia Pacific to Drive Market

The global pharmaceutical continuous manufacturing market is highly competitive due to presence of numerous players, finds Transparency Market Research.

May 21, 2020
·
4 min read
Tissue Banking Market: Increasing demand for regenerative medicines to propel market

Transparency Market Research has published a new report titled, “Tissue Banking Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

May 21, 2020
·
4 min read
Genetown

Fulcrum Therapeutics Announces Multiple Presentations at the 2020 American Academy of Neurology (AAN) Science Highlights Virtual Platform

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, announced multiple presentations at the 2020 American Academy of Neurology Science Highlights Virtual Platform.

May 21, 2020
·
7 min read
Drug Development

Alethia Biotherapeutics Announces Receipt of FDA Authorization to Begin Phase 2 Development for its EMT Inhibitor, AB-16B5

Alethia Biotherapeutics announced that the U.S. Food and Drug Administration has cleared its Phase 2 Investigational new drug application for AB-16B5, a potent inhibitor of the epithelial to mesenchymal transition.

May 21, 2020
·
2 min read
Deals

Dentsply Sirona Declares Quarterly Cash Dividend payable on July 10, 2020

DENTSPLY SIRONA Inc., The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share.

May 21, 2020
·
1 min read
Genetown

BeiGene and Medison Pharma Announce Exclusive Distribution Agreement and Acceptance of New Drug Application for BTK Inhibitor BRUKINSA™ (zanubrutinib) in Israel

BeiGene, Ltd. and Medison Pharma Ltd. announced an exclusive distribution agreement for Medison to commercialize BeiGene’s BTK inhibitor BRUKINSA™ in Israel and the acceptance of a new drug application in Israel for BRUKINSA for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.

May 21, 2020
·
11 min read
N.M. Medical Cannabis Program Sees Record Pace in the First Quarter of 2020Regional analysis shows programmatic inefficiencies, N.M. patients face higher prices due to plant cap

Combined patient sales from the 34 licensed producers in New Mexico’s Medical Cannabis Program totaled $40.1 million for the first quarter of 2020, an increase of $12 million or 43% over reported patient sales in the first quarter of 2019.

May 21, 2020
·
5 min read